Core Viewpoint - A new company, YaoXing (Shanghai) Biopharmaceutical Technology Co., Ltd., has been established with a registered capital of 20 million RMB, fully owned by Sichuan Baili Pharmaceutical Co., Ltd. [1] Company Summary - Company Name: YaoXing (Shanghai) Biopharmaceutical Technology Co., Ltd. [1] - Legal Representative: Zhu Yi [1] - Registered Capital: 20 million RMB [1] - Shareholder: Sichuan Baili Pharmaceutical Co., Ltd. holds 100% [1] - Company Type: Limited liability company (wholly owned by a natural person) [1] - Business Scope: Includes drug production, clinical trial services, drug wholesale, and import/export of drugs [1] Industry Summary - Industry Classification: Manufacturing > Pharmaceutical Manufacturing > Chemical Drug Preparation Manufacturing [1] - Address: 1st Floor, No. 14-15, Banxia Road, Pudong New District, Shanghai [1] - Business Duration: Until December 22, 2025, with no fixed term thereafter [1] - Registration Authority: Pudong New District Market Supervision Administration [1]
曜兴（上海）生物医药科技有限责任公司成立，注册资本2000万人民币
Sou Hu Cai Jing·2025-12-22 21:19